Skip to main content
PMC home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1975 Aug;56(4):299–306.

Adrenal glandular lipids and circulating corticosterone in severely diabetic rats.

B C Wexler, R F Lutmer
PMCID: PMC2072763  PMID: 1174454

Abstract

Young, adult, female Sprague-Dawley rats were fasted for 18 h and then given a single s.c. injection of alloxan (10 mg/100 g body weight) which promptly induced a severe state of diabetes. The animals were killed at frequent time intervals during the 7-day study period in order to record the dynamic changes in their capacity for adrenal steroidogenesis and secretion as measured by fluorometric determination of their circulating corticosterone (Cmpd B) levels as well as by thin layer chromatographic identification of cortical lipid moieties used for steroidogenesis. In addition to severe polydypsia, polyuria and polyphagia, these animals manifested super-normal glucose, triglycerides, free fatty acids and cholesterol in their blood, severe hepatic steatosis, adrenal hyperplasia with lipid depletion from the mineralocorticoid producing z. glomerulosa, thymus gland involution and complete degranulation of their insulin producing islet beta cells. Despite an initial high output of Cmpd B and despite progressive cortical hyperplasia, the serum Cmpd B levels became reduced and many of the animals succumbed suddenly, due most likely to inadequate adrenocortical steroidogenesis. Adrenocortical lipids showed a progressive accumulation of free fatty acids, di- and triglycerides, suggesting that some lipid enzymatic defect could be responsible for the lack of conversion of these lipid entities essential for proper steroidogenesis.

Full text

PDF
300

Images in this article

301Figs. 1-2
on p.301
302Fig. 3
on p.302

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKER B., MAENGWYN-DAVIES G. D., ROSEN D., FRIEDENWALD J. S., WINTER F. C. The adrenal cortex and B-vitamins in diabetic retinopathy. Diabetes. 1954 May-Jun;3(3):175–187. doi: 10.2337/diab.3.3.175. [DOI] [PubMed] [Google Scholar]
  2. CAHILL G. F., Jr, VANCE V. K., URRUTIA G. In vitro metabolism of glucose by adrenals from normal and alloxan-diabetic rats. Diabetes. 1962 Jul-Aug;11:318–320. [PubMed] [Google Scholar]
  3. Conn J. W. Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med. 1965 Nov 18;273(21):1135–1143. doi: 10.1056/NEJM196511182732106. [DOI] [PubMed] [Google Scholar]
  4. Corder C. N., Kalkhoff R. K. Hepatic lipid metabolism in aloxan diabetic rats. J Lab Clin Med. 1969 Apr;73(4):551–563. [PubMed] [Google Scholar]
  5. DEVECERSKI M. S., FRAWLEY T. F. ADRENAL STEROID PRODUCTION IN RATS WITH ALLOXAN DIABETES. Endocrinology. 1963 Sep;73:386–391. doi: 10.1210/endo-73-3-386. [DOI] [PubMed] [Google Scholar]
  6. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  7. Fraley D. S., Totten R. S. An autopsy study of endocrine organ changes in diabetes mellitus. Metabolism. 1968 Oct;17(10):896–900. doi: 10.1016/0026-0495(68)90155-8. [DOI] [PubMed] [Google Scholar]
  8. Freeman C. P., West D. Complete separation of lipid classes on a single thin-layer plate. J Lipid Res. 1966 Mar;7(2):324–327. [PubMed] [Google Scholar]
  9. GUILLEMIN R., CLAYTON G. W., LIPSCOMB H. S., SMITH J. D. Fluorometric measurement of rat plasma and adrenal corticosterone concentration; a note on technical details. J Lab Clin Med. 1959 May;53(5):830–832. [PubMed] [Google Scholar]
  10. Hüther K. J., Scholz H. R. Plasma concentrations and rates of plasma clearance and production of cortisol and corticosterone in healthy persons and in subjects with asymptomatic and clinical diabetes mellitus. Horm Metab Res. 1970 Nov;2(6):357–363. doi: 10.1055/s-0028-1095054. [DOI] [PubMed] [Google Scholar]
  11. Macho L., Saffran M. Metabolism of fatty acids in the rat adrenal gland. Endocrinology. 1967 Aug;81(2):179–185. doi: 10.1210/endo-81-2-179. [DOI] [PubMed] [Google Scholar]
  12. Rudman D., Garcia L. A. Effect of adrenocorticotropin on the concentration of triglyceride in the adrenal gland of the hypophysectomized rat. Endocrinology. 1966 May;78(5):1087–1088. doi: 10.1210/endo-78-5-1087. [DOI] [PubMed] [Google Scholar]
  13. SABA G. C., HOET J. J. The effect of alloxan on the adrenal cortical secretion. I. In male rats. Acta Endocrinol (Copenh) 1962 Jul;40:349–357. doi: 10.1530/acta.0.0400349. [DOI] [PubMed] [Google Scholar]
  14. SLATON P. E., BIGLIERI E. G. HYPERTENSION AND HYPERALDOSTERONISM OF RENAL AND ADRENAL ORIGIN. Am J Med. 1965 Mar;38:324–336. doi: 10.1016/0002-9343(65)90142-7. [DOI] [PubMed] [Google Scholar]
  15. Wexler B. C. Histopathologic responses to severe alloxan diabetes in arteriosclerotic and nonarteriosclerotic rats. Diabetes. 1970 May;19(5):324–336. doi: 10.2337/diab.19.5.324. [DOI] [PubMed] [Google Scholar]
  16. Wexler B. C., Lutmer R. F. Comparison of aortic and adrenal glandular lipids between non-arteriosclerotic and arteriosclerotic rats. Br J Exp Pathol. 1972 Dec;53(6):625–637. [PMC free article] [PubMed] [Google Scholar]
  17. Wexler B. C. Pathophysiologic responses to severe, chronic alloxan diabetes in arteriosclerotic and non-arteriosclerotic rats. Atherosclerosis. 1971 Nov-Dec;14(3):289–307. doi: 10.1016/0021-9150(71)90059-1. [DOI] [PubMed] [Google Scholar]
  18. Wexler B. C., Saroff J., Judd J. Variations in response to severe alloxan diabetes in arteriosclerotic and nonarteriosclerotic rats. Diabetes. 1970 May;19(5):311–323. doi: 10.2337/diab.19.5.311. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES